Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ex McKesson CEO named Quidel chairman

Executive Summary

Former Sandoz Pharma and McKesson CEO Mark Pulido has been named chairman of Quidel, the diagnostics firm announced June 2. Pulido, 51, has been a director of Quidel for two years and was most recently chairman and CEO of BenefitPoint, Inc. Pulido resigned as head of McKesson in 1999 following the disclosure of reporting irregularities associated with the wholesaler's merger with the health information firm HBOC (1"The Pink Sheet" June 28, 1999, p. 6)...

Latest Headlines
See All
UsernamePublicRestriction

Register

PS044108

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel